Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-05

Clinical Trial Update: Predictors of Post-alteplase Hemorrhagic Transformation of Brain Infarction [Phase 4]

View source ↗

Summary

A Phase 4 study from Kafrelsheikh University examines predictors of hemorrhagic transformation after alteplase treatment in ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alteplase (Activase) (alteplase)

Snippet

Sponsor: Kafrelsheikh University | Conditions: Ischemic Stroke, Alteplase Adverse Reaction | Phase 4 | Status: COMPLETED